Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Watt

Showing results (741-750 of 771) with videos related to

Pageof 78
Sort By:
Nature Communications|March 11, 2022
Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic controlMagdalene K Montgomery, Jacqueline Bayliss, Shuai Nie, et al.
Diabetes|May 15, 2013
Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in miceBirgitte Lindegaard, Vance B Matthews, Claus Brandt, et al.
Journal of the American Chemical Society|March 5, 2004
Promotion of iridium-catalyzed methanol carbonylation: mechanistic studies of the cativa processAnthony Haynes, Peter M Maitlis, George E Morris, et al.
Plos One|July 2, 2024
Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potentialNileena Velappan, Sergei S Biryukov, Nathaniel O Rill, et al.
Science Advances|December 15, 2021
Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistanceChrysovalantou E Xirouchaki, Yaoyao Jia, Meagan J McGrath, et al.
Cell Reports. Medicine|April 18, 2025
Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASHWilliam De Nardo, Olivia Lee, Yazmin Johari, et al.
Cancer Research|April 24, 2024
ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain FerroptosisRaj K Shrestha, Zeyad D Nassar, Adrienne R Hanson, et al.
Cell Metabolism|November 26, 2015
Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose MetabolismRuth C Meex, Andrew J Hoy, Alexander Morris, et al.
Cell Metabolism|January 13, 2026
Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at nightThomas Marjot, Kieran Smith, Felix Westcott, et al.
Elife|March 23, 2026
Global molecular landscape of early MASLD progression in human obesityQing Zhao, William De Nardo, Ruoyu Wang, et al.
Pageof 78

Showing results (741-750 of 771) with videos related to

Sort By:
Pageof 78
Nature Communications|March 11, 2022
Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic controlMagdalene K Montgomery, Jacqueline Bayliss, Shuai Nie, et al.
Diabetes|May 15, 2013
Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in miceBirgitte Lindegaard, Vance B Matthews, Claus Brandt, et al.
Journal of the American Chemical Society|March 5, 2004
Promotion of iridium-catalyzed methanol carbonylation: mechanistic studies of the cativa processAnthony Haynes, Peter M Maitlis, George E Morris, et al.
Plos One|July 2, 2024
Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potentialNileena Velappan, Sergei S Biryukov, Nathaniel O Rill, et al.
Science Advances|December 15, 2021
Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistanceChrysovalantou E Xirouchaki, Yaoyao Jia, Meagan J McGrath, et al.
Cell Reports. Medicine|April 18, 2025
Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASHWilliam De Nardo, Olivia Lee, Yazmin Johari, et al.
Cancer Research|April 24, 2024
ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain FerroptosisRaj K Shrestha, Zeyad D Nassar, Adrienne R Hanson, et al.
Cell Metabolism|November 26, 2015
Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose MetabolismRuth C Meex, Andrew J Hoy, Alexander Morris, et al.
Cell Metabolism|January 13, 2026
Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at nightThomas Marjot, Kieran Smith, Felix Westcott, et al.
Elife|March 23, 2026
Global molecular landscape of early MASLD progression in human obesityQing Zhao, William De Nardo, Ruoyu Wang, et al.
Pageof 78